First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
Clinical trial NCT04993443 · TERMINATED
Trial details
- NCT number
- NCT04993443
- Sponsor
- Syneos Health
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-06
- Primary completion
- 2023-03-02
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.